Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier (Q39821262)

14 September 2017

Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier (English)

1 reference

14 September 2017

1 reference

4

1 reference

14 September 2017

Birk Poller

1

1 reference

14 September 2017

Jürgen Drewe

series ordinal

2

1 reference

14 September 2017

Stephan Krähenbühl

series ordinal

3

1 reference

14 September 2017

Heike Gutmann

series ordinal

5

1 reference

14 September 2017

23 July 2009

1 reference

Cellular and Molecular Neurobiology

14 September 2017

1 reference

14 September 2017

30

1 reference

14 September 2017

1

1 reference

14 September 2017

63-70

1 reference

https://scigraph.springernature.com/pub.10.1007/s10571-009-9431-1

14 September 2017

0 references

cites work

Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10571-009-9431-1

Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT.

21 January 2018

1 reference

12 December 2020

Brain accumulation of dasatinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by elacridar treatment

1 reference

12 December 2020

Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier

1 reference

12 December 2020

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

12 December 2020

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

1 reference

12 December 2020

Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.

1 reference

12 December 2020

The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies

1 reference

12 December 2020

Peripheral cytokines profile in Parkinson's disease.

1 reference

12 December 2020

The blood-brain barrier in neuroinflammatory diseases

1 reference

12 December 2020

Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls

1 reference

12 December 2020

Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein

1 reference

12 December 2020

Localisation of breast cancer resistance protein in microvessel endothelium of human brain

1 reference

12 December 2020

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

12 December 2020

Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood–brain barrier

1 reference

12 December 2020

Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

1 reference

12 December 2020

The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib

1 reference

12 December 2020

ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.

1 reference

12 December 2020

An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amin

1 reference

12 December 2020

A new multidrug resistance protein at the blood-brain barrier

1 reference

12 December 2020

Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors

1 reference

12 December 2020

Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier.

1 reference

12 December 2020

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

1 reference

12 December 2020

Clinical relevance of P-glycoprotein in drug therapy

1 reference

12 December 2020

The influence of cytokines on the integrity of the blood-brain barrier in vitro.

1 reference

12 December 2020

Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).

1 reference

12 December 2020

Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein

1 reference

12 December 2020

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

12 December 2020

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

1 reference

12 December 2020

Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier

1 reference

12 December 2020

10.1007/S10571-009-9431-1

Identifiers

DOI

1 reference

14 September 2017

1 reference